Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

257 results about "Enterococcus bacteria" patented technology

Probiotic composition for preventing and treating Anti-tumor treatment-related diarrhea and use thereof

PCT designated stage expiredWO2024251031A1Antibacterial agentsBacteriaBiotechnologyTumor therapy
The present invention relates to the technical field of microorganisms. Provided are a probiotic composition and a use thereof in the preparation of a product for preventing and / or treating anti-tumor treatment-related diarrhea and other health conditions. Active ingredients of the probiotic composition comprise Bifidobacterium bifidum, Enterococcus avium, Ligilactobacillus salivarius, Limosilactobacillus fermentum, and Parabacteroides distasonis. The probiotic composition has good safety, auto-aggregation capacity, antioxidant capacity, short-chain fatty acid production capacity, in-vitro cell adhesion capacity, capacity to inhibit multiple pathogenic bacteria, and capacity to treat anti-tumor treatment-related diarrhea, etc.
Owner:SICHUAN ANAEROBIC BIOTECHNOLOGY CO LTD

Enterococcus pluvialis and application of exosome of enterococcus pluvialis

InactiveCN119144523AExosomes purereduce inflammation levelsBacteriaMicroorganism based processesBiotechnologyMyocarditis
The invention discloses application of enterococcus pluvialis and exosomes thereof, and relates to the field of application of enterococcus pluvialis and exosomes thereof. The enterococcus pluvialis disclosed by the invention is enterococcus pluvialis Zz-2024, is preserved in the General Microbiological Culture Collection Center of the China Committee for Culture Collection of Microorganisms, and has a preservation number of CGMCC (China General Microbiological Culture Collection Center) No. 31249. The invention relates to an exosome produced by Enterococcus pluvialis Zz-2024, and an application of the exosome in a medicine for treating myocarditis, and particularly relates to an exosome produced by Enterococcus pluvialis Zz-2024 and an application of the exosome in a medicine for treating myocarditis. The enterococcus pluvialis exosome disclosed by the invention has excellent effects in experiments of inhibiting myocarditis factors, reducing lipid droplet aggregation, inhibiting myocardial cell senescence and the like, and breaks through the limitation that human stem cell source exosomes are adopted in related fields at present.
Owner:HARBIN MEDICAL UNIVERSITY

Probiotic composition for preventing and treating anti-tumor treatment associated diarrhea and application thereof

PendingCN119074775AHas self-agglutination/co-agglutinationAntioxidantAntibacterial agentsBacteriaBiotechnologyLactobacillus salivarius
The invention belongs to the technical field of microorganisms. The invention relates to a probiotic composition and application thereof in preparation of products for preventing and / or treating health conditions such as anti-tumor treatment related diarrhea. The probiotic composition comprises the following active ingredients: bifidobacterium bifidum, enterococcus faecalis, lactobacillus salivarius, lactobacillus fermentum mucus and parabacteroides didysonii. The probiotic composition has good safety, self-agglutination capability, oxidation resistance, short-chain fatty acid production capability, in-vitro cell adhesion capability, capability of inhibiting a plurality of pathogenic bacteria, capability of treating anti-tumor treatment related diarrhea and the like.
Owner:SICHUAN ANAEROBIC BIOTECHNOLOGY CO LTD

Ten antibacterial peptides and application thereof in preparation of antibacterial infection drugs

The invention relates to application of ten antibacterial peptides in the antimicrobial field. The ten antibacterial peptides have strong antibacterial activity on multi-drug-resistant bacteria, including but not limited to gram-negative bacteria such as escherichia coli, pseudomonas aeruginosa, acinetobacter baumannii, klebsiella pneumoniae and the like, and gram-positive bacteria such as staphylococcus aureus, enterococcus faecalis and the like. Activity research proves that any one of the ten antibacterial peptides has a remarkable effect of inhibiting, killing or preventing microbial infection. Due to the strong antibacterial property of any antibacterial peptide, the antibacterial peptide has wide application potential in the aspects of preparing antibacterial drugs, preservatives, antibacterial coatings, antibacterial fibers, antibacterial packaging materials and the like. Due to the unique property of the antibacterial peptide in the aspect of antibacterial performance, a new direction is provided for the development of efficient and reliable antibacterial agents and antibacterial technologies and products in multiple fields.
Owner:王刚

Strain of diffusion carbon pad bacteria LUCF 4343-3, bacterial agent and application of bacterial agent in preparation of antibacterial agent

The invention belongs to the technical field of antibacterial active microorganisms, and particularly relates to a strain of diffusion carbon pad bacteria LUCF 4343-3, a bacterial agent and application of the bacterial agent in preparation of an antibacterial preparation. According to the invention, an endophytic fungus strain with remarkable antibacterial potential is successfully separated from Parmotrema, and the endophytic fungus strain is identified as diffusion carbon pad fungus LUCF 4343-3. Experiments show that an ethyl acetate extract of the strain shows a good inhibition effect on various clinical common pathogenic bacteria, including gram-positive bacteria (staphylococcus aureus and enterococcus faecalis), gram-negative bacteria (pseudomonas aeruginosa), fungi (candida albicans and candida glabrata) and the like; the discovery provides an important basis for the application of the strain in the development of novel broad-spectrum antibacterial drugs.
Owner:LIAOCHENG UNIV

Functional probiotic composition and application thereof

The invention discloses a functional probiotic composition and application thereof, and relates to the technical field of microbial engineering. Bifidobacterium longum, lactobacillus acidophilus and enterococcus faecalis are combined to serve as a microbial agent, the microbial agent and active substances of the tea leaves form a composition, then the composition is combined with prebiotics, it is ensured that viable bacteria directly reach the intestinal tract through a microencapsulation technology, and the effect of improving the immune function is achieved; tea polyphenol in the active substances of the tea leaves can serve as a carbon source of prebiotics to stimulate proliferation of the bifidobacterium longum and the lactobacillus acidophilus, so that the acid resistance and intestinal colonization capacity of the microbial inoculum are enhanced, and meanwhile, theanine in the active substances of the tea leaves, the bifidobacterium longum and the lactobacillus acidophilus synergistically promote secretion of gamma-aminobutyric acid, so that the effect of improving the intestinal colonization is achieved. And the tea polyphenol can inhibit the large intestine rod from adhering to the intestinal mucosa, and the probiotic agent secretes antibacterial peptide, so that the integrity of the intestinal barrier is maintained together.
Owner:JIANGSU BEIXING BIOTECHNOLOGY CO LTD

Persistent deodorization type cat litter partner as well as preparation method and application thereof

The invention relates to a persistent deodorization type cat litter partner as well as a preparation method and application thereof. The cat litter mate is prepared by compounding nano zinc chloride, bacillus subtilis powder and enterococcus faecium powder according to a specific proportion, and has an excellent deodorization effect. The bacillus subtilis and enterococcus faecium powder can secrete various enzymes and bacteriocin, effectively decompose odor substances and inhibit growth of putrefying bacteria, and tolerate the bactericidal effect of nano zinc chloride at the same time. The cat litter mate provided by the invention can significantly reduce the concentration of ammonia gas and volatile organic compounds, has the advantages of long-acting deodorization, environmental protection and safety, and is suitable for the field of pet breeding.
Owner:BIOMAX ECOLOGICAL ENG

Amycolatopsis serissoides (Amycolatopsis serissoides) WQ 127309 and application of Amycolatopsis serissoides (Amycolatopsis serissoides (Amycolatopsis serissoides (Amycolatopsis serissoides) WQ 127309

ActiveCN119060905Aantiproliferative activityInhibitory activityAntibacterial agentsAntimycoticsStaphyloccocus aureusAmycolatopsis
The invention discloses a potential new strain of amycolatopsis serissoides (Amycolatopsis serissoides WQ 127309) and an application of the potential new strain of the amycolatopsis serissoides WQ 127309. The amycolatopsis sp. WQ 127069 provided by the invention is preserved in the China Center for Type Culture Collection, and the preservation number is CCTCC M 20241536. The bacterial strain has obvious broad-spectrum inhibition effects on gram-positive bacteria (staphylococcus aureus, bacillus subtilis, mycobacterium tuberculosis, enterococcus faecalis and sarcina luteus), gram-negative bacteria (escherichia coli, proteus mirabilis and pseudomonas aeruginosa) and fungi (candida albicans); meanwhile, the strain has a very strong inhibition effect on HepG 2 and Hela cell proliferation, provides a strain resource and a theoretical basis for development and application of antibiotics and antitumor drugs, and has a relatively good market application prospect.
Owner:YUNNAN UNIV

Preparation method and application of immobilized beads of deodorizing bacteria

The present invention discloses a preparation method and application of an immobilized pellet of deodorizing bacteria. The present invention has the following beneficial effects: (1) the present invention adopts raw materials such as polyvinyl alcohol, boric acid, sodium alginate, and calcium chloride to prepare the immobilized pellet of Enterococcus hirae IDO5, and the required equipment is simple and the preparation process is simple; (2) the immobilized pellet prepared by the present invention enlarges the contact area between the deodorizing microorganism Enterococcus hirae IDO5 and odorous substances, enhances the microorganism's resistance to the influence of adverse environment, and improves the adsorption and degradation efficiency of odorous substances; (3) the immobilized pellet of Enterococcus hirae IDO5 has a good deodorizing effect, with a degradation rate of indole in pig manure wastewater as high as 93.0%, and a degradation rate of skatole as high as 81.6%. It is applied to livestock and poultry breeding manure and breeding wastewater to effectively reduce the concentration of odorous substances such as indole and skatole, and can effectively reduce the odor pollution caused by livestock and poultry breeding.
Owner:ANIMAL SCI RES INST GUANGDONG ACADEMY OF AGRI SCI

Urinary system infection pathogen and drug resistance gene detection system and kit

The invention discloses a urinary system infection pathogen and drug resistance gene detection system and a kit. The detection system comprises forward and reverse primers which are respectively used for detecting escherichia coli, staphylococcus aureus, acinetobacter baumannii, klebsiella pneumoniae, enterococcus faecium, candida glabrata, proteus mirabilis, enterococcus faecalis, candida tropicalis, enterobacter cloacae, candida albicans, pseudomonas aeruginosa and streptococcus agalactiae; the forward primer and the reverse primer are respectively used for detecting the blaCTX-M gene of the extended spectrum beta-lactamase, the forward primer and the reverse primer are used for detecting the blaSHV gene of the extended spectrum beta-lactamase, and the forward primer and the reverse primer are used for detecting the blaTEM gene of the extended spectrum beta-lactamase. According to the forward and reverse primers for detecting the blaNDM gene of the extended-spectrum beta-lactamase, a detection sample is urine. According to the invention, common gram-negative bacteria, gram-positive bacteria and fungi can be detected at the same time, and the problem of missed detection of mixed infection in traditional culture is solved.
Owner:WUHAN ADICON CLINICAL LAB

Composite microecological preparation for aquatic products as well as preparation method and application of composite microecological preparation

The invention discloses a compound micro-ecological preparation for aquatic products as well as a preparation method and application thereof, and belongs to the technical field of micro-ecological preparations. The microecological preparation disclosed by the invention comprises clostridium butyricum, bacillus licheniformis, enterococcus faecalis and lactobacillus plantarum. The microecological preparation is combined with concentrated cottonseed protein for use, can replace fish meal, is added into feed, can remarkably improve the immunocompetence, oxidation resistance and digestive enzyme activity of animals, and can improve the relative abundance of beneficial bacteria in intestinal tracts, inhibit the growth of pathogenic bacteria and regulate the microecological balance of the intestinal tracts after entering the intestinal tracts of the animals. According to the invention, aerobic bacteria and anaerobic bacteria are cooperatively used, oxygen in the surrounding environment is greatly consumed by bacillus licheniformis and enterococcus faecalis, the proliferation of beneficial bacteria such as clostridium butyricum and lactobacillus plantarum is promoted, and the probiotic effect is fully played.
Owner:GUANGDONG OCEAN UNIVERSITY

Enterococcus faecalis EF-1 capable of reducing blood lipid, microbial preparation and application of enterococcus faecalis EF-1

The invention relates to the technical field of microorganisms, in particular to enterococcus faecalis EF-1 capable of reducing blood lipid, a microbial preparation and application of the enterococcus faecalis EF-1. The enterococcus faecalis EF-1 is preserved in the China General Microbiological Culture Collection Center (CGMCC) on September 27, 2024, and the preservation number is CGMCC No.32097. The enterococcus faecalis EF-1 is named as enterococcus faecalis EF-1. The enterococcus faecalis EF-1 has the functions of: (1) relieving the weight increase speed of animals, reducing body weight gain, and preventing, relieving or treating obesity; (2) the contents of triglyceride, cholesterol and low-density lipoprotein cholesterol in liver and serum are reduced; (3) the liver function is protected, and the contents of ALT and AST in serum and liver are reduced; (4) liver lipid deposition and lesion are relieved; (5) relieving adipose tissue hypertrophy; (6) preventing, relieving or treating metabolic syndrome; (7) reducing blood sugar, improving insulin resistance and relieving diabetes mellitus; 8, increasing the content of short-chain fatty acid; and (9) regulating intestinal flora.
Owner:FEED RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Enterococcus faecium and application thereof in cigar tobacco leaf fermentation

The invention discloses enterococcus faecium and application thereof in cigar tobacco leaf fermentation. The enterococcus faecium is classified and named as enterococcus faecium, and is preserved in the China General Microbiological Culture Collection Center (CGMCC), the preservation number is CGMCC No.31715, and the preservation date is August 21, 2024. The enterococcus faecium can be used for preparing the enterococcus faecium, and the enterococcus faecium is named as enterococcus faecium and is preserved in the China General Microbiological Culture Collection Center (CGMCC). When the enterococcus faecium is used for improving cigar tobacco leaf raw materials, especially domestic cigar tobacco leaves, the technological process is simple, and reaction conditions are mild; after fermentation treatment, the aroma quality of the domestic cigar tobacco leaves is obviously improved, the sweetness of the smoke is improved, the irritation is reduced, the offensive odor is reduced, and the aftertaste and the sweet aftertaste are obviously improved. The method has the characteristics of simplicity, practicability, obvious effect and the like, and is expected to be popularized and applied in industry.
Owner:CHINA TOBACCO ANHUI IND CO LTD

A kind of Macleaya powder and flavonoids natural supramolecular hydrogel and its application as antibacterial and anti-inflammatory drug

The present invention provides a type of supramolecular hydrogel compound formed by self-assembly of effective ingredients of Macleaya cordata powder and flavonoid active molecules, a structure, a preparation method and an application. The supramolecular hydrogel compound has excellent selective antibacterial ability. While selectively killing pathogenic bacteria such as Staphylococcus aureus, it does not affect the activity of probiotics such as Bacillus subtilis and Enterococcus faecium in the intestine; it is particularly sensitive to methicillin-resistant Staphylococcus aureus (MRSA); it also has good anti-inflammatory effects and promotes wound healing. Among them, the natural supramolecular hydrogel formed by the self-assembly of effective ingredients of Macleaya cordata powder and flavonoid active molecules has a uniform morphology, good dispersion and stability, forms a gel without the need for excipients, and has the value of being developed into a carrier-free drug delivery preparation. The general structural formula of the compound is shown below:
Owner:BEIJING UNIV OF CHINESE MEDICINE

Compound microbial agent for preventing and treating fusarium wilt of cotton and application of compound microbial agent

The invention discloses a compound microbial agent for preventing and treating fusarium wilt of cotton and application of the compound microbial agent, and belongs to the technical field of biological prevention and treatment of plant diseases. The prepared compound microbial agent is obtained by mixed culture of clostridium butyricum JBH-BD1 fermentation centrifugate, enterococcus faecium JBHBIO-BSC1, glucose and bacillus subtilis JBH-BK8, the preparation method is simple, and industrialized production, popularization and application are facilitated. The compound microbial agent has an obvious inhibition effect on cotton fusarium wilt caused by fusarium oxysporum, and the bacteriostasis rate reaches 66.7%. The harm of the cotton fusarium wilt to cotton is effectively reduced by utilizing a biotechnology, meanwhile, compared with a chemical agent, the problems of environmental pollution and the like are effectively avoided, and the application prospect is very wide.
Owner:HENAN JINBAIHE BIOTECH CO LTD

Composition containing three lactic acid bacteria strains and application of composition to prevention of EHP of white shrimps

The invention discloses a composition containing three lactic acid bacteria strains and an application of the composition in prevention of EHP (Ethylene Hypothionyl Phthalate) of white shrimps. The three lactic acid bacteria strains provided by the invention are respectively enterococcus faecium EF08, lactobacillus plantarum LP28 and lactobacillus acidophilus LA1063. The mass ratio of the enterococcus faecium EF08 to the lactobacillus plantarum LP28 to the lactobacillus acidophilus LA1063 is 1 to 3 to 0.01. Experiments show that the P1 and P2 combined probiotic strain has the application of preventing and reducing EHP disease infection of the white shrimps. Therefore, the composition disclosed by the invention can be used for preparing a medicine for preventing microsporidia EHP infection.
Owner:SYNBIOTECH BIOTECHNOLOGY YANGZHOU CO LTD

Crispr enzymes, methods, systems and uses thereof

The present invention provides novel systems, methods, and compositions for the preparation and use of recombinant engineered novel Cas9 enzymes optimized for human cells for nucleic acid targeting and manipulation. The invention is based on the discovery of a novel Cas9 enzyme from the following items: streptococcus equi ATCC 33317, enterococcus hirsuti strain F1129E, streptococcus equi strain AG46, staphylococcus pseudomonas strain 19, streptococcus intermedius B196 strain G1552, streptococcus sanguis SK330, streptococcus C150, oral streptococcus subspecies oral strain RH173508, oral streptococcus SK313, staphylococcus warneri strain 691 and staphylococcus squirrel strain SNUC 2430. The present invention relates to novel Cas9 enzymes for use in human cells by codon optimization and recombinantly production, e.g., streptococcus gallate strain AM24-4, Lactobacillus curapae strain Biut2, and Streptococcus suis strain LSS83 bacteria, which novel Cas9 enzymes are codon optimized and recombinantly produced for use in human cells. In some embodiments, a novel Cas9 enzyme may be used for base editing. In some embodiments, the novel engineered Cas9 enzymes are used to treat human diseases.
Owner:BEAM THERAPEUTICS INC

Enterococcus lactis NSK220, microbial inoculum and application

The invention belongs to the technical field of food microorganisms, and particularly relates to an enterococcus lactis NSK220 strain, a microbial agent and application of the enterococcus lactis NSK220 strain. The invention provides the enterococcus faecium NSK220, the clearance rate of the enterococcus faecium NSK220 on DPPH is very high, the serum SOD enzyme activity can be improved by supplementing the strain NSK220 in diet, and it is indicated that the oxidation resistance of the strain NSK220 is high. Meanwhile, the enterococcus faecium NSK220 has relatively strong self-cohesion and surface hydrophobicity, which indicates that the strain has strong colonization ability and is beneficial to long-term play of probiotic functions in intestinal tracts; the strain NSK220 can also improve the feed intake and kidney function of animals, and is beneficial to the growth and body health of the animals. The enterococcus faecium NSK220 has an inhibition effect on escherichia coli, staphylococcus aureus, salmonella, pseudomonas aeruginosa and listeria monocytogenes.
Owner:QINGDAO VIP PET HEALTH PROD

Enterococcus faecium capable of simultaneously degrading three mycotoxins and application of enterococcus faecium

The invention discloses enterococcus faecium capable of degrading three mycotoxins at the same time and application of the enterococcus faecium, and belongs to the technical field of microorganisms. The enterococcus faecium JBHBIO-BSC1 disclosed by the invention is preserved in the China Center for Type Culture Collection, and the preservation number of the enterococcus faecium JBHBIO-BSC1 is CCTCC (China Center for Type Culture Collection) NO: M 20241918. The enterococcus faecium disclosed by the invention has the most remarkable characteristic that the enterococcus faecium has an obvious degradation effect on the aflatoxin, the vomitoxin and the zearalenone, and the degradation rates of the aflatoxin, the vomitoxin and the zearalenone can respectively reach 74.67%, 85.83% and 82.12%. The enterococcus faecium disclosed by the invention is natural, safe, acid-resistant, alkali-resistant and high-temperature-resistant, and has relatively strong organic acid production capacity. In addition, the strain has an obvious inhibition effect on escherichia coli, salmonella and staphylococcus aureus, and is expected to be applied to the fields of food processing and microbial pharmacy.
Owner:HENAN JINBAIHE BIOTECH CO LTD

Strain of enterococcus faecalis, composite bacterial agent and applications thereof

A strain of Enterococcus faecalis, a composite bacterial agent, and application thereof, which relates to the field of microbiology. The Enterococcus faecalis strain was deposited on Oct. 13, 2022, at the Guangdong Microbial Culture Collection Center (GDMCC) with the deposit number GDMCC No. 62869. Both the Enterococcus faecalis strain and the composite bacterial agent can effectively treat intestinal disorders and inflammatory bowel disease in felines and can be used in the preparation of related pharmaceuticals.
Owner:HEALTH & HAPPINESS H&H HONG KONG LTD

Wide-spectrum bacteriophage EFH2 capable of eliminating enterococcus faecalis suffering from humans and animals

The invention discloses a wide-spectrum bacteriophage EFH2 capable of eliminating enterococcus faecalis suffering from humans and animals, and relates to the technical field of biology. The wide-spectrum bacteriophage is preserved in the China Center for Type Culture Collection on September 26, 2024, and the preservation number of the wide-spectrum bacteriophage is CCTCC NO: M 20242087. The wide-spectrum bacteriophage EFH2 is a newly found bacteriophage, has good tolerance under the conditions that the pH is 3-9 and the temperature is 4-60 DEG C, and has the titer as high as 2.31 * 10 < 8 > PFU / mL after being cultured for 8 hours under the condition that the MOI is 0.01. The wide-spectrum bacteriophage EFH2 is wide in antibacterial spectrum, short in incubation period, high in outbreak amount, capable of rapidly killing host bacteria, small in toxic and side effect, high in safety, wide in temperature and acid-base tolerance range, good in hydrophilicity and capable of well killing and disinfecting animals infected with multi-drug-resistant enterococcus and environments and food polluted by enterococcus.
Owner:HUAZHONG AGRI UNIV

Enterococcus faecalis bacteriophage as well as preparation method and application thereof

The invention discloses an enterococcus faecalis bacteriophage and application thereof, and relates to the field of bioengineering, on the basis that E. faecalis YN772 is obtained through separation, E. faecalis YN772 is taken as host bacteria to be co-cultured with stomatological sewage which is not subjected to chlorine treatment, enterococcus faecalis lytic bacteriophage PEf772 is separated, the bacteriophage is preserved in China Center for Type Culture Collection (CCTCC), the preservation number is CCTCC NO: M 20241844, the preservation date is August 26, 2024, the preservation number is CCTCC NO: M 20241844, and the preservation number is CCTCC NO: M 20241844. According to the research on physiological characteristics, the phage PEf772 belongs to a tail phage and a myelocaudaceae phage, the infection temperature range is 20-42 DEG C, the optimum temperature is 37 DEG C, and the phage PEf772 has high-temperature tolerance and has activity when the pH value is 3-12. In addition, the bacteriophage PEf772 not only can efficiently and continuously remove an E.faecalis YN772 biological membrane, but also can effectively inhibit the growth of the E.faecalis YN772, and a new thought and a potential treatment strategy are provided for clinically treating the refractory periapical periodontitis caused by enterococcus faecalis.
Owner:KUNMING YANAN HOSPITAL (KUNMING CADRE NURSING HOME)

Cytochalasin compound with wide antibacterial activity as well as preparation method and application of cytochalasin compound

The invention discloses a cytochalasin compound with wide antibacterial activity as well as a preparation method and application thereof. According to the present invention, the cytochalasin polymer is obtained by separation from the fermentation product derived from the Aspergillus izzukae (Aspergillus izzukae), such that the cytochalasin polymer can be obtained, the preservation number of the Aspergillus izzukae PJ03-11 is CGMCC (China General Microbiological Culture Collection Center) No.40601, and the preservation number of the Aspergillus izzukae PJ03-11 is CGMCC No.40601. The compound has a structure of a cytochalasin mother nucleus and an epiccine mother nucleus, and shows good activity in the aspects of inhibiting or killing staphylococcus aureus, methicillin-resistant staphylococcus aureus, multidrug-resistant staphylococcus aureus, streptococcus pneumoniae, staphylococcus epidermidis and vancomycin-resistant enterococcus faecalis; the compound can be used for preparing novel agricultural or medical antibacterial drugs.
Owner:INST OF MICROBIOLOGY CHINESE ACAD OF SCI

Preparation and application of cephalomycin derivative with gram-positive bacterium activity resistance

The invention discloses preparation and application of a hand mycin derivative with gram-positive bacterium activity resistance, and belongs to the technical field of medicine preparation. According to the present invention, the ctd gene cluster is subjected to heterologous expression in the strain Streptomyces lividans TK64, such that the obtained hand mycin derivatives Carpatamide N and Carpatamide O show excellent biological activity on the gram-positive bacteria; the MIC (minimal inhibitory concentration) values of the Carpamide N and the Carpamide O on streptococcus faecium and enterococcus faecium are 4 mu g / mL and 1 mu g / mL respectively; the MIC (minimal inhibitory concentration) values for staphylococcus aureus and bacillus subtilis are respectively 0.25 mu g / mL and 0.125 mu g / mL, the MIC values for MRSA (Methicillin-Resistant Staphylococcus Aureus) are respectively 1 mu g / mL and 0.5 mu g / mL, and the Gram-positive bacterium resisting activity of the compound is equivalent to or better than that of vancomycin.
Owner:CHONGQING UNIV OF TECH

Preparation and application of sour horse milk-derived lactobacillus plantarum, enterococcus faecalis and composite freeze-dried microbial inoculum with synergistic probiotic function

PendingCN121294270AAntibacterial agentsBacteriaBiotechnologyMare milk
According to the invention, the traditional fermented koumiss in Xinjiang is collected, two novel multifunctional probiotic strains, namely, the lactobacillus plantarum SR6 GDMCC NO.66817 strain and the enterococcus faecalis SM5 GDMCC NO.66816 strain with good compatibility are separated and screened out, and the two strains have the characteristics of reducing blood fat, reducing cholesterol, removing triglyceride, resisting oxidation and antagonizing pathogenic bacteria, and have the characteristics of good cholate and gastrointestinal tract tolerance, high survival rate and good safety. The growth characteristics and compatibility of the two strains are improved; the inhibition rate of cholesterol esterase and pancreatic lipase; the method comprises the following steps: evaluating the triglyceride removal rate, antioxidant activity, pathogenic bacterium resistance, artificially simulated gastrointestinal fluid tolerance, strain drug resistance and safety, compounding lactobacillus plantarum SR6 and enterococcus faecalis SM5 strains according to a ratio of 1: 1 to prepare a freeze-dried bacterial agent, and keeping good survival rate (pgt; 0.05) and functional characteristics, the strain can be used as a functional direct vat set starter and is directly applied to production of fermented dairy products, and the biological activity of food is improved.
Owner:YILI NALA DAIRY GRP CO LTD +1

Enterococcus faecium XL and application thereof

The invention discloses an enterococcus faecium XL, and the preservation number of the enterococcus faecium XL is CGMCC (China General Microbiological Culture Collection Center) No. 28133. The enterococcus faecium XL and the application thereof have the following beneficial effects: 1, the enterococcus faecium XL provided by the invention can grow and metabolize under an oil reservoir condition to generate lactic acid organic acid, dissolve carbonate in a rock stratum, increase the permeability of the rock stratum, degrade heavy components in crude oil, relieve crude oil blockage in an oil layer, increase the liquid amount and improve the oil reservoir quality; the oil recovery rate is improved; 2, the enterococcus faecium XL is applied to microorganism single-well throughput, the average single-well oil increasing amount is greater than 400 tons, and the validity period is more than 200 days; and 3, the enterococcus faecium XL is applied to microbial oil displacement, the average daily oil increase of a well group is more than 5 tons, and the water content drop amplitude is more than 5%.
Owner:CHINA PETROLEUM & CHEMICAL CORP +1

Application of Xinjiang medicine mulberry extract in preparation of medicine for treating or preventing periapical periodontitis

PendingCN121371004AAntibacterial agentsAntipyreticDisinfectantPeriapical disease
The invention relates to the technical field of medicines, and particularly discloses application of a Xinjiang medicine mulberry extract in preparation of a medicine for treating or preventing periapical periodontitis, which is technically characterized in that the Xinjiang medicine mulberry extract is found and proved to have a remarkable inhibition effect on periapical periodontitis key pathogenic bacterium enterococcus faecalis for the first time, the minimum inhibitory concentration (MIC) is 0.604 mg / mL, and the Xinjiang medicine mulberry extract has a remarkable inhibition effect on the periapical periodontitis key pathogenic bacterium enterococcus faecalis. The minimum bactericidal concentration (MBC) is 1.875 mg / mL, and a biological membrane can be effectively inhibited and removed; in-vivo experiments of a rat periapical periodontitis model prove that the extract can remarkably reduce the number of bacteria in root canals and relieve periapical bone destruction, the curative effect is equivalent to that of calcium hydroxide, and the extract is non-toxic to main organs and high in biocompatibility. The invention provides a new candidate and a clear technical scheme for developing an efficient and low-toxicity natural plant source root canal disinfectant.
Owner:FIRST AFFILIATED HOSPITAL OF XINJIANG MEDICAL UNIVERSITY

Biomarker for individual recognition and application thereof

The invention relates to a biomarker for individual recognition and application thereof, and relates to the technical field of biology. The biomarker comprises at least one of the following microorganisms: propionibacterium acnes, staphylococcus epidermidis, marine paracoccus, streptococcus, rhodococcus fence celebrating, staphylococcus, pseudomonas, streptococcus sanguineus, achromobacter xylosoxidans, acinetobacter calcoaceticus, acinetobacter johnsonii, staphylococcus lentus, pseudomonas toralaris and brevundimonas vesicularis. Or enterococcus faecium. The biomarker can provide analysis with higher resolution in the aspect of differential strain information, has a better distinguishing effect, higher accuracy and sensitivity on individual recognition, and can be used as a new technical means for supplementing forensic individual recognition.
Owner:SOUTHERN MEDICAL UNIVERSITY

Bacterial lysins and uses thereof

PendingUS20260183372A1BiotechnologyLysin
A general formula for lysins based on which the activity and functionality are further screened and 24 lysins are identified and further investigated, nine of which are characterized. These lysins exhibit potent bactericidal activity, capable of lysing multiple species of Staphylococcus, Streptococcus, and / or Enterococcus; demonstrate robust environmental resistance and stability, retaining activity under varying temperatures, NaCl concentrations, pH levels, and in immune serum; and effectively treat localized and systemic infections. These lysins and their variants are promising as antimicrobial agents for eradicating bacteria, preventing bacterial infections, or treating bacterial infections (caused by genera Staphylococcus, Streptococcus, and / or Enterococcus).
Owner:HUAZHONG AGRI UNIV

Application of GSK2018682 in preparation of gram-positive bacterial infection resisting medicine

PendingCN120392760AOrganic active ingredientsAntibacterial agentsGram-positive bacterial infectionsStaphyloccocus aureus
The invention provides an application of GSK2018682 in preparation of a medicine for resisting gram-positive bacterial infection, and the GSK2018682 has a CAS number of 1034688-30-6. The invention also provides an application of the GSK2018682 in preparation of a medicine for resisting gram-positive bacterial infection. According to the technical scheme, the novel medical application of the GSK2018682 is disclosed, and the GSK2018682 has good antibacterial activity and anti-biofilm activity on various gram-positive bacteria and can inhibit growth of staphylococcus aureus, staphylococcus epidermidis, enterococcus faecalis, enterococcus faecium and the like and formation of biofilms.
Owner:SHENZHEN NANSHAN DISTRICT PEOPLES HOSPITAL